Leveraging and Harnessing Generative Artificial Intelligence to Mitigate the Burden of Neurodevelopmental Disorders

Obinna Ositadimma Oleribe1,2

  • 1Department of Health Sciences, School of Public Health and Health Sciences, California State University, Dominguez Hills, Carson, CA 90747, USA.

PubMed

Insights

Generative Artificial Intelligence (GenAI) can significantly improve early identification and diagnosis of neurodevelopmental disorders (NDDs). Strategic use of GenAI enhances personalized treatments and accelerates research, reducing associated mortality and morbidity.

Area of Science:

  • Pediatric Neurology
  • Artificial Intelligence in Healthcare
  • Developmental Psychology

Background:

  • Neurodevelopmental disorders (NDDs) present significant challenges in early identification, diagnosis, and treatment.
  • Overlapping symptoms, lack of biomarkers, stigma, and systemic barriers complicate NDD management.
  • Existing healthcare systems struggle to provide timely and effective care for affected children and families.

Purpose of the Study:

  • To explore the transformative potential of Generative Artificial Intelligence (GenAI) in neurodevelopmental disorder management.
  • To highlight how GenAI can address current challenges in NDD screening, diagnosis, and treatment.
  • To advocate for policy changes integrating GenAI into NDD care systems.

Main Methods:

  • Review of current applications and potential future uses of GenAI in NDD management.
  • Analysis of GenAI's impact on diagnostic efficiency, treatment personalization, and research acceleration.
  • Discussion of the benefits of GenAI for early identification, clinical decision support, and family support.

Main Results:

  • GenAI can enhance early identification and screening for NDDs.
  • GenAI may reduce diagnostic processing times by up to 90% and improve clinical decision support.
  • Personalized therapy regimens using GenAI show significant improvements in attention measures (36%) and accuracy (81-84%) compared to clinician plans.
  • GenAI accelerates research, customizes learning materials, and improves treatment monitoring and family support.

Conclusions:

  • GenAI offers powerful solutions to improve the identification, diagnosis, and treatment of NDDs.
  • Strategic integration of GenAI can lead to more individualized and effective care, reducing NDD-related mortality and morbidity.
  • Policy initiatives are crucial to facilitate the widespread adoption of GenAI in NDD management.